$20.95
-1.04 (-4.73%)
LUNR News28 articles
Lunai Bioworks Shares Surge on Nasdaq Compliance Filing
Lunai Bioworks shares surged 80.88% after hours to $5.15 after Nasdaq confirmed compliance with the $1 minimum bid-price rule, averting delisting risk, though the company remains under a one-year panel monitor and has expressed substantial doubt about its ability to continue operations.
Futures Rise on US-Iran Deal Hopes; SpaceX IPO Soars
Stock futures rose Sunday after reports of a US-Iran peace deal reopening the Strait of Hormuz, sending oil prices down over 4%. SpaceX surged 19% in its Nasdaq debut, with a record $75 billion IPO.
ARK Invest Acquires 3.3 Million SpaceX Shares on IPO Day, Exits Teradyne, Iridium, Archer
ARK Invest acquired nearly 3.3 million SpaceX shares on its IPO day, funding the purchase by selling stakes in Teradyne, Iridium, Twist Bioscience, and Archer Aviation.
Space Stocks Reel as SpaceX's $2.1 Trillion Debut Reshapes Sector
SpaceX's $75B IPO sent shockwaves through the space sector, with smaller players like Rocket Lab and AST SpaceMobile hit hard. All eyes are on AST's upcoming satellite launch.
SpaceX Soars 19% on Nasdaq Debut, Musk Becomes First Trillionaire
SpaceX surged 19% on its first trading day, closing at $160.95 and achieving a $2.1 trillion market cap. Elon Musk's net worth hit trillionaire status, while Virgin Galactic and Rocket Lab shares fell sharply.
SpaceX IPO Triggers Sector Rotation Away from Smaller Space Stocks
SpaceX's IPO surged 19% to $160.95, sparking a broad selloff in space stocks as investors rotated capital. Rocket Lab fell 10.8%, AST SpaceMobile dropped 15.5%.
Wall Street Edges Higher on SpaceX IPO Surge and Falling Oil Prices
U.S. stocks closed higher on Friday, lifted by a strong SpaceX debut and lower oil prices. The S&P 500 rose 0.5% to 7,431.46, while the Dow gained 0.7%.
Redwire Shares Tumble on $500M ATM Dilution Fears; Space Sector Rotates
Redwire shares plunged 11.6% on heavy volume after unveiling a $500 million ATM equity program, sparking dilution fears amid a broader rotation out of smaller space stocks following SpaceX's market debut.
SpaceX IPO Buzz Lifts Intuitive Machines, but Dilution and Contract Losses Linger
Intuitive Machines shares jumped 15.49% as space stocks rallied ahead of SpaceX's Nasdaq debut, but a $500M share sale and missed NASA rover contract pose risks.
Firefly Aerospace Shares Soar 18% on SpaceX IPO Buzz
Firefly Aerospace stock surged 18% to $39.37 following SpaceX's $75 billion IPO pricing, sparking a rally in space equities. The stock still trades below its $48 follow-on offering price.
Redwire Stock Tumbles 25% as Space Sector Selloff Overpowers Strawberry Contract Win
Redwire Corp (RDW) shares plunged 25% this week to $18.45 after Jefferies downgraded the stock to Hold, citing limited near-term upside. A space-agriculture contract win failed to offset a broad selloff in speculative space stocks.
Intuitive Machines Plunges 15% on $500M ATM Stock Sale Plan
Intuitive Machines shares fell 15.6% after announcing a $500 million at-the-market stock sale program, raising dilution concerns as the company seeks flexible funding for growth.
Starfighters Space Soars Amid Sector Decline; Capital Infusion Fuels Rally
Starfighters Space shares jumped 29% on a $17.5 million equity deal, even as the company faces no revenue, a $26 million lawsuit, and going-concern doubts.
Redwire Drops 16% on Downgrade Amid Space Sector Selloff
Redwire shares plunged 16.4% to $20.53 after Jefferies downgraded the stock to Hold, citing valuation concerns. The broader space sector also retreated.
Space ETF Navigates Blue Origin Setback and SpaceX IPO Anticipation
Tema Space Innovators ETF slipped 3.97% Friday after Blue Origin's rocket explosion, but the fund still posted a 3.6% weekly gain. SpaceX's $4.16B defense contract and IPO plans keep space stocks in focus.
Space Stocks Stumble After Blue Origin Rocket Explodes; SpaceX IPO Valuation Trimmed
Space stocks retreated Friday after a Blue Origin rocket explosion halted a rally. SpaceX's IPO valuation target is reportedly lowered to at least $1.8 trillion.
Intuitive Machines Slips After Losing Out on Key NASA Lunar Rover Contract
Intuitive Machines shares dropped 8.1% after NASA awarded key lunar rover contracts to competitors. The company remains engaged in other NASA lunar projects.
Sidus Space Soars 24% on Revenue Growth, Dilution Concerns Loom
Sidus Space shares jumped 24.2% to $5.13 on Friday, driven by a strong Q1 update showing revenue growth and a narrower net loss. However, the company remains unprofitable and faces cash burn risks.
Space Force Contract Win Propels Intuitive Machines Shares Higher Ahead of Earnings
Intuitive Machines shares jumped 8.35% in premarket trading after securing a spot on the U.S. Space Force's Andromeda contract, with a raised ceiling of over $6.2 billion, ahead of Thursday's earnings report.
Intuitive Machines Surges 20% Ahead of Lunar Mission and Earnings
Intuitive Machines shares surged 20.2% to $28.97, reversing a prior drop, ahead of its Q1 earnings report and a key lunar mission test.
LUNR Surges 20% as Space Stocks Rally Ahead of Earnings Report
Intuitive Machines stock surged 20% to $28.97 on heavy call option volume ahead of its May 14 earnings report, joining a broader space sector rally led by Rocket Lab's 34% jump.
Rocket Lab Shares Surge 6% Ahead of Earnings, Neutron Update
Rocket Lab stock gained nearly 6% in Monday trading as investors positioned for next week's quarterly results and a timeline update for its Neutron rocket. Trading volume exceeded 13.9 million shares.
Intuitive Machines Stock Soars 13% Amid Heavy Trading and High Short Interest
Shares of Intuitive Machines surged 13% to $19.75 in early trading Monday, with volume exceeding 44 million shares. High short interest of 25% continues to fuel volatility as investors await NASA milestones and March earnings.
Intuitive Surgical Dips Despite Record Highs for Nasdaq and S&P 500
Intuitive Surgical shares slipped 3.1% last week to $424.64, even as the Nasdaq and S&P 500 reached new records. Q1 revenue rose 23% to $2.77 billion, but tariff risks and a drop in bariatric procedures kept investors cautious.
Intuitive Surgical Dips on Goldman Sachs Price Target Cut Amid Medtech Weakness
Intuitive Surgical shares slid over 4% after Goldman Sachs cut its price target to $558. The medtech giant posted strong Q1 revenue growth but faces tariff and competitive headwinds.
Intuitive Surgical Drops to 52-Week Low on Recall and Competition Fears
Intuitive Surgical shares fell to a 52-week low Monday after an FDA recall and lowered procedure growth forecasts, overshadowing a strong Q1 earnings beat.
Intuitive Surgical Hits 52-Week Low on FDA Class I Recall, Tariff Worries
Intuitive Surgical shares dropped 6.6% to a 52-week low after the FDA classified a recall of its SureForm stapler reloads as Class I, citing four injuries and one death. Strong Q1 earnings were overshadowed by tariff and safety concerns.
Intuitive Surgical Shares Surge on Upgraded Forecast, Robust da Vinci Sales
Intuitive Surgical shares climbed to $482.22 after the company raised its 2026 growth outlook and reported a 23% revenue jump to $2.77 billion in Q1, driven by strong da Vinci system placements.